|
ACE genotype and allele distributions among controls and migraine patients in different studies |
||||||
| Genotypes |
Alleles |
|||||
|
|
||||||
| N |
DD(%) |
ID(%) |
II(%) |
D(%) |
I(%) |
|
|
|
||||||
| Controls |
||||||
| Tronvik |
403 |
92 (26.6) |
204 (50.6) |
107 (22.8) |
388 (48.1) |
418 (51.9) |
| Paterna (ref 8) |
201 |
75 (37.3) |
101 (50.3) |
25 (12.4) |
251 (62.4) |
151 (37.6) |
| Lea (ref 9) |
244 |
76 (31.1) |
122 (50.0) |
46 (18.9) |
274 (56.1) |
214 (43.9) |
| Kowa (ref 10) |
248 |
31 (12.5) |
114 (46.0) |
103 (41.5) |
176 (35.5) |
320 (64.5) |
| Migraine |
||||||
| Tronvik |
347 |
78 (22.5) |
186 (53.6) |
83 (23.9) |
342 (49.3) |
352 (50.7) |
| Paterna |
302 |
146 (48.3) |
129 (42.7) |
27 (9.0) |
421 (69.7) |
183 (30.3) |
| Lea |
250 |
77 (30.8) |
142 (56.8) |
31 (12.4) |
296 (59.2) |
204 (40.8) |
| Kowa |
176 |
33 (18.7) |
86 (48.9) |
57 (32.4) |
152 (43.2) |
200 (56.8) |
| MwA subgroup |
||||||
| Tronvik |
155 |
34 (21.9) |
87 (56.1) |
34 (21.9) |
155 (50.0) |
155 (50.0) |
| Paterna |
NA |
NA |
NA |
NA |
NA |
NA |
| Lea |
151 |
48 (31.8) |
85 (56.3) |
18 (11.9) |
181 (59.9) |
121 (40.1) |
| Kowa |
54 |
14 (25.9)* |
26 (48.2) |
14 (25.9) |
54 (50.0)* |
54 (50.0) |
| MoA subgroup |
||||||
| Tronvik |
187 |
43 (23.0) |
96 (51.3) |
48 (25.7) |
182 (48.7) |
192 (51.3) |
| Paterna |
302 |
146 (48.3)* |
129 (42.7) |
27 (9.0) |
421 (69.7) |
183 (30.3) |
| Lea |
99 |
29 (29.3) |
57 (57.6) |
13 (13.1) |
115 (58.1) |
83 (41.9) |
| Kowa |
122 |
19 (15.6) |
60 (49.2) |
43 (35.2) |
98 (35.2) |
146 (59.8) |
|
* Reported significant finding for genotype or allele frequencies | ||||||
Tronvik et al. BMC Neurology 2008 8:4 doi:10.1186/1471-2377-8-4 |
||||||